Receptors, Thrombin, antagonists & inhibitors
- Name
- Receptors, Thrombin, antagonists & inhibitors
- Accession Number
- DBCAT001737
- Description
Not Available
- Drugs
Drug Drug Description Vorapaxar A platelet aggregation inhibitor used to reduce thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or peripheral arterial disease (PAD). Atopaxar Atopaxar has been investigated for the treatment of Coronary Artery Disease and Acute Coronary Syndrome. - Drugs & Drug Targets
Drug Target Type Vorapaxar Proteinase-activated receptor 1 target Vorapaxar Cytochrome P450 3A4 enzyme Vorapaxar Cytochrome P450 2J2 enzyme Vorapaxar P-glycoprotein 1 transporter